Donate Help Contact The AHA Sign In Home
American Heart Association
Hypertension
Search: search_blue_button Advanced Search
Hypertension. 2007;49:672-678
Published online before print December 26, 2006, doi: 10.1161/01.HYP.0000254486.00883.3d
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Data Supplement
Right arrow All Versions of this Article:
49/3/672    most recent
01.HYP.0000254486.00883.3dv1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Armando, I.
Right arrow Articles by Jose, P. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Armando, I.
Right arrow Articles by Jose, P. A.
Right arrowPubmed/NCBI databases
*Compound via MeSH
*Substance via MeSH
Medline Plus Health Information
*High Blood Pressure
Related Collections
Right arrow Other hypertension

(Hypertension. 2007;49:672.)
© 2007 American Heart Association, Inc.


Original Articles, Part 2

Reactive Oxygen Species–Dependent Hypertension in Dopamine D2 Receptor–Deficient Mice

Ines Armando; Xiaoyan Wang; Van Anthony M. Villar; John E. Jones; Laureano D. Asico; Crisanto Escano; Pedro A. Jose

From the Department of Pediatrics and Physiology and Biophysics, Georgetown University Medical Center, Washington, DC.

Correspondence to Ines Armando, Department of Pediatrics, Georgetown University Medical Center, 4000 Reservoir Rd, NW, Washington, DC 20057. E-mail ma383{at}georgetown.edu

Dysfunction of D2-like receptors has been reported in essential hypertension. Disruption of D2R in mice (D2–/–) results in high blood pressure, and several D2R polymorphisms are associated with decreased D2R expression. Because D2R agonists have antioxidant activity, we hypothesized that increased blood pressure in D2–/– is related to increased oxidative stress. D2–/– mice had increased urinary excretion of 8-isoprostane, a parameter of oxidative stress; increased activity of reduced nicotinamide-adenine dinucleotide phosphate oxidase in renal cortex; increased expression of the reduced nicotinamide-adenine dinucleotide phosphate oxidase subunits Nox1, Nox2, and Nox4; and decreased expression of the antioxidant enzyme heme-oxygenase-2 in the kidneys, suggesting that regulation of reactive oxygen species (ROS) production by D2R involves both pro-oxidant and antioxidant systems. Apocynin, a reduced nicotinamide-adenine dinucleotide phosphate oxidase inhibitor, or hemin, an inducer of heme oxigenase-1, normalized the blood pressure in D2–/– mice. Because D2Rs in the adrenal gland are implicated in aldosterone regulation, we evaluated whether alterations in aldosterone secretion contribute to ROS production in this model. Urinary aldosterone was increased in D2–/– mice and its response to a high-sodium diet was impaired. Spirolactone normalized the blood pressure in D2–/– mice and the renal expression of Nox1 and Nox4, indicating that the increased blood pressure and ROS production are, in part, mediated by impaired aldosterone regulation. However, spironolactone did not normalize the excretion of 8-isoprostane and had no effect on expression of Nox2 or heme-oxygenase-2. Our results show that the D2R is involved in the regulation of ROS production and that, by direct and indirect mechanisms, altered D2R function may result in ROS-dependent hypertension.


Key Words: aldosterone • mineralocorticoids • genetics-animal models • hypertension, kidney




This article has been cited by other articles:


Home page
Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
C. S. Escano, I. Armando, X. Wang, L. D. Asico, A. Pascua, Y. Yang, Z. Wang, Y.-S. Lau, and P. A. Jose
Renal dopaminergic defect in C57Bl/6J mice
Am J Physiol Regulatory Integrative Comp Physiol, December 1, 2009; 297(6): R1660 - R1669.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
M.-L. Zhuo, Y. Huang, J.-Z. Chen, L.-H. Sun, R.-F. Yang, H.-Z. Chen, X. Lv, H.-L. Li, Y.-S. Wei, G. Liu, et al.
Endothelium-specific overexpression of human IC53 downregulates endothelial nitric oxide synthase activity and elevates systolic blood pressure in mice
Cardiovasc Res, November 1, 2009; 84(2): 292 - 299.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
B. Yao, R. C. Harris, and M.-Z. Zhang
Intrarenal Dopamine Attenuates Deoxycorticosterone Acetate/High Salt-Induced Blood Pressure Elevation in Part Through Activation of a Medullary Cyclooxygenase 2 Pathway
Hypertension, November 1, 2009; 54(5): 1077 - 1083.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
C. Hu, S. D. DePuy, J. Yao, W. E. McIntire, and P. Q. Barrett
Protein Kinase A Activity Controls the Regulation of T-type CaV3.2 Channels by G{beta}{gamma} Dimers
J. Biol. Chem., March 20, 2009; 284(12): 7465 - 7473.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
C. Zeng, I. Armando, Y. Luo, G. M. Eisner, R. A. Felder, and P. A. Jose
Dysregulation of dopamine-dependent mechanisms as a determinant of hypertension: studies in dopamine receptor knockout mice
Am J Physiol Heart Circ Physiol, February 1, 2008; 294(2): H551 - H569.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
E. Silva and P. Soares-da-Silva
Reactive oxygen species and the regulation of renal Na+-K+-ATPase in opossum kidney cells
Am J Physiol Regulatory Integrative Comp Physiol, October 1, 2007; 293(4): R1764 - R1770.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
Z. Wang, I. Armando, L. D. Asico, C. Escano, X. Wang, Q. Lu, R. A. Felder, C. G. Schnackenberg, D. R. Sibley, G. M. Eisner, et al.
The elevated blood pressure of human GRK4{gamma} A142V transgenic mice is not associated with increased ROS production
Am J Physiol Heart Circ Physiol, May 1, 2007; 292(5): H2083 - H2092.
[Abstract] [Full Text] [PDF]